Global Market Study on HAIs Control: Cleaning and Sterilization to Witness Highest Growth by 2020


  • Published On : Jan-2015 |
  • Pages : 108 Pages |
  • Format :

Hospital-acquired infections (HAIs) refer to the infections that are acquired by patients during their stay in hospitals. These infections are caused by the transmission of pathogens, such as bacteria, viruses, fungi, and parasites, from one patient to another, or from a healthcare worker to a patient. Lack of proper sanitation in hospitals, poor infrastructure, and lack of awareness among healthcare workers are some of the common causes that are boosting the number of HAI cases. In addition, lack of training and poor infection control practices in hospitals also lead to the spreading of HAIs. Some other factors influencing the spread of HAIs include age and nutritional status. Aged people and people suffering from malnutrition have decreased levels of immunity and thus are more prone to acquire HAIs. HAIs are caused by the direct or indirect transmission of microbes. Globally, factors such as increasing government initiatives for controlling HAIs and rising prevalence of HAIs cases have helped in the growth of HAIs market. 

North America dominates the global HAIs market. The U.S. represents the largest market for HAIs control in the North American region. This is due to technical advancements and more focus on improved healthcare facilities in the region. Asia is expected to experience high growth rate in the next five years in HAIs control market. This is due to high prevalence of HAIs in the region and increasing demand for improved healthcare facilities. 

Some of the major factors that are driving the global market for HAIs control market include growing prevalence of HAIs, increasing initiatives by government and non-government organizations and rising aging population. However, factors such as lack of primary healthcare infrastructure in developing countries and lack of awareness about HAIs are restraining the global HAIs control market. Rising number of product launches and increasing popularity of gas plasma sterilization technology are some of the latest trends that have been observed in the global HAIs control market. 

This report provides in-depth analysis and estimation of the HAIs control market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The HAIs control market is categorized on the basis of type of method, types of cleaning and sterilization techniques, diagnostics techniques, treatments, diseases and geography. Based on type of cleaning and sterilization techniques, the HAIs control market comprises instrument sterilization, wide-area sterilization, disinfection of linen. Based on type of diagnostic techniques, the market comprises manual testing, automated testing and confirmation testing. Based on the type of pharmaceutical treatment, the market comprises of viral HAI pharmaceuticals, bacterial HAI pharmaceuticals and fungal HAI pharmaceuticals. Based on the type of environmental treatment, the market comprises of air treatment, water treatment and chemical treatment. Based on the type of diseases, the market comprises of pneumonia, gastrointestinal illnesses, urinary tract infections (UTI), surgical site infections and primary bloodstream infections.

In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). North America is further segmented into the U.S. and rest of North America. Similarly, Europe is further segmented into Germany, France, U.K. and rest of Europe. Asia is further segmented into China, Japan and rest of Asia.

Hospital-acquired infections (HAIs), also known as nosocomial infections, refer to infections that are acquired by patients during their stay in hospitals. Globally, the HAIs control market is witnessing significant growth due to high prevalence of various hospital infections and increasing aging population. In addition, rising number of initiatives undertaken by government and nongovernment organizations and hot and humid environmental conditions are driving the HAIs control market. However, factors such as lack of primary healthcare facilities and infrastructure and limited awareness about HAIs in developing regions are restraining the global market for HAIs control. Increasing popularity of gas plasma sterilization technology is one of the major trends that have been observed in the HAIs control market. The global HAIs control market is estimated at USD 50,807.0 million in 2014. It is likely to grow with a CAGR of 8.5% and reach USD 82,889.4 million in 2020.

North America has the largest market for the HAIs control market. North America market for HAIs control is estimated at USD 21,319.2 million in 2014 and is expected to reach USD 34,430.3 million in 2020, growing at a CAGR of 8.3%. Diagnostic techniques are the largest segment in the overall HAIs control market. In terms of diseases, pneumonia is the largest segment. In terms of growth, Asia is the fastest growing region, cleaning and sterilization is the fastest growing segment and primary bloodstream infections are the fastest growing type of HAIs.

STERIS Corporation is a leading player for cleaning and sterilization in the overall HAIs control market, with a share of about 25% of the cleaning and sterilization market in 2013. Getinge AB accounts for about 24% of the global cleaning and sterilization market for HAIs control. Some of the other major players in HAIs control market are Advanced Sterilization Products Division Ethicon US, LLC, Cepheid, Pfizer, Inc, Hoffmann-La Roche, Ltd., Becton, Dickinson and Company and Kimberly-Clark Corporation.

Some of the major players in the cleaning and sterilization segment in HAIs control market

  • Advanced Sterilization Products Division Ethicon US, LLC.
  • STERIS Corporation.
  • Cepheid.
  • Cantel Medical.
  • Getinge AB.
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Hoffmann-La Roche, Ltd.
  • Becton, Dickinson and Company.
  • Kimberly-Clark Corporation.
  • bioMerieux SA.
  • Other
Back To Top